Media releases
November 17, 2006
November 17, 2006
November 13, 2006
November 07, 2006
November 06, 2006
Novartis creates new strategic biomedical R&D center in Shanghai
October 25, 2006
Tyzeka(TM) receives US regulatory approval as a new treatment for patients with chronic hepatitis B
October 23, 2006
New Zelnorm® data demonstrate relief of multiple symptoms of dysmotility-type dyspepsia
October 20, 2006
Glivec® approved in the US for five rare life-threatening disorders with limited treatment options
October 19, 2006
Novartis Animal Health expands presence in Japan with acquisition
October 19, 2006
The information in the press releases on these pages was factually accurate on the date of publication. These press releases remain on Novartis website for historical purposes only. Novartis assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.
Event calendar
Find out about past and upcoming events (e.g. sales results, pipeline updates and shareholder meetings) and download presentations.